[3] Xue Y, Liu X, Hu P. Higher risk of disease progression in the grey zone relative to inactive Chronic hepatitis B. AASLD2024, Abstract (296). [4] Wang J, Zhang Z, Xia J, et al. Treatment eligibility of pa...
参考文献: Lee HW, Ahn SH, Kim K, et al. Protective Effects of MASLD in Chronic Hepatitis B Patients on the Risk for Hepatocellular Carcinoma, Hepatic Decompensation, and Mortality. AASLD2024. Abstract (410). END 重庆 ...
[2] Do AT, Yu ML, Toyoda H, et al. The prevalence and natural history of diverse subtypes of indeterminate phase chronic hepatitis B: results of the international REAL-B cohort. AASLD2024, Abstract (402). [3] Xue Y, Liu X, Hu P. Higher risk of disease progression in the grey zone...
4. Zhang HF, et al. The efficacy of antiviral therapy for HBVinfected children: A largescale, multicenter prospective study (sprout project) - an interim analysis. AASLD 2024 Abstract 2612.
[2] Liu C, Verheyen J, Kum DB, et al. Capsid assembly modulators such as ALG-001075 induce profound HBV DNA knockdown and directly target HBeAg in vitro. AASLD2024, Abstract (294).
因此,慢乙肝患者应积极采取合适的治疗策略,不断提升临床治愈率,追求更好的远期结局。 参考文献: Ju WH. Comparative analysis of clinical efficacy and safety of combined pegylated interferon a-2b in 489 patients with chronic hepatitis B. AASLD 2024. Abstract (328). END...
Zhao Jing, Ren Shan, Zheng Sujun, et al. 32.2% of inactive HBsAg carriers achieved clinical cure at 48 weeks with pegylated interferon alpha-2b therapy: A multicenter real-world study (STARHB PROJECT in china) - 2-year data update. AASLD 2024 Abstract 399...
Rui FJ, Yeo YH, Ni WJ, et al. The impact of concurrent chronic hepatitis B infection on the diagnostic accuracy of FIB-4 in individuals with metabolic-associated steatotic liver disease (MASLD). AASLD2024. Abstract (426). END
AASLD2024, Abstract (307).[2]Ju WH. Comparative analysis of clinical efficacy and safety of combined pegylated interferon a-2b in 489 patients with chronic hepatitis B. AASLD 2024. Abstract (328).[3]Liang HQ, Zheng XT, Liu YY, et al. Effects of different antiviral treatments on liver ...
Rui FJ, Yeo YH, Ni WJ, et al. The impact of concurrent chronic hepatitis B infection on the diagnostic accuracy of FIB-4 in individuals with metabolic-associated steatotic liver disease (MASLD). AASLD2024. Abstract (426).